Aarhus University Seal

Free radicals generated by tantalum implants antagonize the cytotoxic effect of doxorubicin

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Little is known about the interaction between antineoplastic drugs and implants in bone cancer patients. We investigated the interaction between commercially available porous tantalum (Ta) implants and the chemotherapeutic drug, Doxorubicin (DOX). DOX solutions were prepared in the presence of Ta implant. The changes in fluorescence intensity of the DOX chromophore were measured by spectrofluorometry and the efficacy of DOX was evaluated by viability of rabbit rectal tumor cells (VX2). After 5 min interaction of the DOX solution (5 μg/ml) with the Ta implant, the fluorescent intensity of the DOX solution was 85% degraded, and only 20% the drug efficacy to kill VX2 cells was retained. However, after adding a reducing agent, Dithiothreitol (DTT, 10 μg/ml), 80% of the original fluorescence and 50% of the drug efficacy were restored while UV irradiation enhanced drug degradation in the presence of Ta implant. The action of DTT and UV irradiation indicated that reactive oxygen species (ROS) were involved in the drug degradation mechanism. We detected that Ta implants in aqueous medium produced hydroxyl radicals. Cells showed higher intracellular ROS activity when culture medium was incubated with the Ta implant prior to cell culture. It is concluded that the porous Ta implant antagonizes the cytotoxicity of DOX via ROS generation of the porous Ta implant.
Original languageEnglish
JournalInternational Journal of Pharmaceutics
Pages (from-to)214-20
Number of pages7
Publication statusPublished - 2013

    Research areas

  • Animals, Antibiotics, Antineoplastic, Cell Line, Tumor, Cell Survival, Dithiothreitol, Doxorubicin, Prostheses and Implants, Rabbits, Reactive Oxygen Species, Tantalum, Ultraviolet Rays

See relations at Aarhus University Citationformats

ID: 70855981